Enzalutamide in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: A retrospective Korean multicenter study in a real-world setting

Enzalutamide in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: A retrospective Korean multicenter study in a real-world setting

Purpose: This study aimed to evaluate the clinical efficacy of enzalutamide in chemotherapy-naïve metastatic castration-resistant prostate cancer (mCRPC) patients using real-world data from Korean patients. Materials and Methods: We retrospectively reviewed the medical records of 199 chemotherapy-na...

Full description

Bibliographic Details
Main Authors:	Seung Il Jung, Myung Soo Kim, Chang Wook Jeong, Cheol Kwak, Sung Kyu Hong, Seok Ho Kang, Jae Young Joung, Seung Hwan Lee, Seok Joong Yun, Tae-Hwan Kim, Sung Woo Park, Seong Soo Jeon, Minyong Kang, Ji Youl Lee, Byung Ha Chung, Jun Hyuk Hong, Hanjong Ahn, Choung-Soo Kim, Dong Deuk Kwon
Format:	Article
Language:	English
Published:	Korean Urological Association 2020-01-01
Series:	Investigative and Clinical Urology
Subjects:	androgen antagonists neoplasm metastasis prostate neoplasms treatment outcome
Online Access:	https://www.icurology.org/Synapse/Data/PDFData/2020ICU/icu-61-19.pdf

Similar Items

Use of docetaxel plus androgen deprivation therapy for metastatic hormone-sensitive prostate cancer in Korean patients: A retrospective study
by: Whi-An Kwon, et al.
Published: (2019-05-01)

The PREVAIL trial of enzalutamide in men with chemotherapy-naïve, metastatic castrationresistant prostate cancer: Post hoc analysis of Korean patients
by: Choung-Soo Kim, et al.
Published: (2016-05-01)

Survival outcomes and prognostic factors for first-line abiraterone acetate or enzalutamide in patients with metastatic castration-resistant prostate cancer
by: Chi-Shin Tseng, et al.
Published: (2023-06-01)

Progression-directed therapy in patients with oligoprogressive castration-resistant prostate cancer
by: Jun Nyung Lee, et al.
Published: (2024-03-01)

Phase I/IIa trial of androgen deprivation therapy, external beam radiotherapy, and stereotactic body radiotherapy boost for high-risk prostate cancer (ADEBAR)
by: Yeon Joo Kim, et al.
Published: (2020-10-01)

Clinical Significance of Serum Adipokines according to Body Mass Index in Patients with Clinically Localized Prostate Cancer Undergoing Radical Prostatectomy
by: Minyong Kang, et al.
Published: (2018-01-01)

Androgen Deprivation Therapy in Patients with Prostate Cancer is Associated with the Risk of Subsequent Alzheimer’s Disease but Not with Vascular Dementia
by: Jong Won Kim, et al.
Published: (2022-07-01)

Nomogram using transrectal ultrasound-derived information predicting the detection of high grade prostate cancer on initial biopsy
by: In Gab Jeong, et al.
Published: (2013-06-01)

The establishment of KORCC (KOrean Renal Cell Carcinoma) database
by: Seok-Soo Byun, et al.
Published: (2016-01-01)

Frailty of Prostate Cancer Patients Receiving Androgen Deprivation Therapy: A Scoping Review
by: Jeongok Park, et al.
Published: (2024-04-01)

Detection of recurrence sites using 18F-fluorocholine PET/CT in prostate cancer patients with PSA failure
by: Dong-Yun Kim, et al.
Published: (2023-06-01)

Ectopic Mediastinal Parathyroid Adenoma in a Patient with Chronic Kidney Disease: A Case Report
by: Dong Min Choo, et al.
Published: (2019-01-01)

Questioning the evidence behind the Saturation Model for testosterone replacement therapy in prostate cancer
by: Jin Wook Kim
Published: (2020-05-01)

The platelet-to-lymphocyte ratio as a significant prognostic factor to predict survival outcomes in patients with synchronous metastatic renal cell carcinoma
by: Hyeong Dong Yuk, et al.
Published: (2020-09-01)

Risk factors for bone loss with prostate cancer in Korean men not receiving androgen deprivation therapy
by: Sun-Ouck Kim, et al.
Published: (2009-04-01)

Intravesical Recurrence after Radical Nephroureterectomy in Patients with Upper Tract Urothelial Carcinoma Is Associated with Flexible Diagnostic Ureteroscopy, but Not with Rigid Diagnostic Ureteroscopy
by: Jee Soo Ha, et al.
Published: (2022-11-01)

Impact of clinical trial participation on survival in patients with castration-resistant prostate cancer: a multi-center analysis
by: Kyo Chul Koo, et al.
Published: (2018-04-01)

Stromal Expression of MicroRNA-21 in Advanced Colorectal Cancer Patients with Distant Metastases
by: Kyu Sang Lee, et al.
Published: (2016-07-01)

Solitary Bladder Metastasis of Prostate Cancer Mimicking Bladder Submucosal Tumor: A Case Report
by: Doo Ri Kim, et al.
Published: (2017-09-01)

Androgen deprivation therapy is associated with decreased second primary lung cancer risk in the United States veterans with prostate cancer
by: Kyungsuk Jung, et al.
Published: (2018-08-01)

Testosterone Replacement Therapy in Men with Untreated or Treated Prostate Cancer: Do We Have Enough Evidences?
by: Myong Kim, et al.
Published: (2021-10-01)

Establishment of Korean prostate cancer database by the Korean Urological Oncology Society
by: Hanjong Ahn, et al.
Published: (2017-11-01)

The utility of two-dimensional shear wave elastography for predicting prostate cancer: a preliminary study
by: Seong Soo Jeon, et al.
Published: (2023-07-01)

Partial Androgen Insensitivity Syndrome Presenting with Gynecomastia
by: Sung Won Lee, et al.
Published: (2015-06-01)

Changes in prostate-specific antigen kinetics during androgen-deprivation therapy as a predictor of response to abiraterone in chemonaïve patients with metastatic castration-resistant prostate cancer
by: Chung-Lin Lee, et al.
Published: (2022-09-01)

Prediction of pathologic upgrading in Gleason score 3+4 prostate cancer: Who is a candidate for active surveillance?
by: Duc Minh Pham, et al.
Published: (2020-07-01)

The Expression of Androgen Receptor and Its Variants in Human Prostate Cancer Tissue according to Disease Status, and Its Prognostic Significance
by: Sung-Woo Park, et al.
Published: (2019-01-01)

Endoscopic Features of Submucosal Invasion in Undifferentiated-type Early Gastric Cancer Less than 20 mm in Size without Ulceration
by: Su Jin Kim, et al.
Published: (2021-06-01)

Clinical and histopathologic analysis of gynecological cancer: a single institute experience over 7 years
by: Soo-Young Lee, et al.
Published: (2020-07-01)

Enzalutamide + androgen deprivation therapy (ADT) versus flutamide + ADT in Japanese men with castration‐resistant prostate cancer: AFTERCAB study
by: Hiroji Uemura, et al.
Published: (2022-01-01)

A single-center long-term experience of active surveillance for prostate cancer: 15 years of follow-up
by: Sang Hun Song, et al.
Published: (2021-01-01)

Mental health care utilization among men with castration‐resistant prostate cancer receiving abiraterone or enzalutamide
by: Phoebe A. Tsao, et al.
Published: (2023-08-01)

Androgen deprivation therapy during and after post-prostatectomy radiotherapy in patients with prostate cancer: a case control study
by: Myong Kim, et al.
Published: (2018-03-01)

Aggressive Supratentorial Ependymoma, Fusion-Positive with Extracranial Metastasis: A Case Report
by: Seong-Ik Kim, et al.
Published: (2017-11-01)

Risk factors for prostate-specific antigen persistence in pT3aN0 prostate cancer after robot-assisted laparoscopic radical prostatectomy: a retrospective study
by: Jun Seop Kim, et al.
Published: (2023-10-01)

High Tumor Burden Predicts Poor Response to Enzalutamide in Metastatic Castration-Resistant Prostate Cancer Patients
by: Yu-Ting Hsieh, et al.
Published: (2021-08-01)

Imaging features of the PI-RADS for predicting extraprostatic extension of prostate cancer: systematic review and meta-analysis
by: Moon Hyung Choi, et al.
Published: (2023-05-01)

Pulmonary Metastasis Originated from Uterine Sarcoma, Presenting as Multiple Nodules with Tortuous, Serpentine, Aneurysmal, Dilated Intratumoral Vessels: A Case Report
by: Hyeon Ji Jang, et al.
Published: (2018-04-01)

Is Preoperative Work-Up Colonoscopy Necessary for Patient with Gastric Cancer?
by: Hee Chan Yang, et al.
Published: (2016-12-01)

Subclassification of pathologically organ-confined (pT2) prostate cancer does not significantly predict postoperative outcomes in Korean males
by: Min Ho Lee, et al.
Published: (2020-01-01)